Accession Number: | 0001193805-21-000014 |
Date: | 2021-01-04 |
Issuer: | ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) |
Original Submission Date: |
CHIVUKULA PAD
C/O ARCTURUS THERAPEUTICS HOLDINGS INC.
10628 SCIENCE CENTER DRIVE, SUITE 250
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-01-04 | S | 10,000 | d | $46.40 | 682,548 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the sales reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | reflects the weighted average price of 10,000 shares of common stock of arcturus therapeutics holdings inc. sold by the reporting person in multiple transactions on january 4, 2021 with sale prices ranging from $43.74 to $50.36 per share. the reporting person undertakes to provide upon request by the u.s. securities and exchange commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |